Will Maier

Senior Vice President, Drug Development Solutions at ICON Biotech

Speaker

Responsibilities

In his current role Will works with pharmaceutical companies throughout the world to provide regulatory, strategic and scientific guidance on medical treatment development and commercialization with a focus on Rare Disease.

Education

•PG Dip (Organisational Development), Tavistock Institute, London, UK - 2009

•Ph.D. (Epidemiology), University of North Carolina, Chapel Hill, US – 1995

•M.P.H. (Epidemiology and Biostatistics), San Diego State University, US – 1989

•B.A. (Biology and Cell Biology), University of California, San Diego, US - 1986

Employment history

Dr. Maier has over 27 years of experience in drug development and commercialisation at pharmaceutical companies in Europe, Canada, the United States and Asia,as well as over 16 years of experience working for ICON Clinical Research.